ArticleOncotarget2015

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.

Min Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.